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 Children infected with HIV are at risk for 
developing renal diseases, including HIV-
associated nephropathy (HIVAN). In a 
pediatric population, HIVAN is charac-
terized by persistent proteinuria associ-
ated with mesangial hyperplasia and / or 
global or focal segmental glomeruloscle-
rosis, in combination with microcystic 
transformation of renal tubules and rapid 
progression to chronic renal failure. 1 
HIVAN tends to occur late in HIV infec-
tion when children are carrying excep-
tionally high viral loads, making children 
who lack access to antiviral therapies par-
ticularly susceptible to the development 
of HIVAN. 1 Renal biopsy is the only 
de( nitive method of diagnosing HIVAN 
at the present time. Given the viral load 
these children carry, the invasive nature of 
renal biopsy makes it an extremely high-
risk procedure to both the patient and the 
health professional performing the proce-
dure. A noninvasive assessment, such as 
use of urinary biomarkers, would be a 
highly desirable diagnostic alternative if 
biomarkers can reliably predict who will 
develop HIVAN. 
 Soler-Garc í a and collaborators 2 (this 
issue) take a rational approach in their search 
for biomarkers of HIVAN progression 
by focusing on growth factors that are 
known to influence the particular 
 pathologies that de( ne HIVAN. - eir 
candidate diagnostic urinary biomarker 
pro( le includes epidermal growth factor 
(EGF), fibroblast growth factor-2 
(FGF-2), and matrix metalloproteinase-2 
(MMP-2). EGF was studied because it 
plays key roles in renal development, 
renal tubule homeostasis, and the patho-
genesis of renal cystic disease. Urinary 
EGF declines in HIV-infected children 
who develop HIVAN relative to infected 
children who do not develop HIVAN, as 
well as to uninfected children ( Figure 1 ). 2 
Renal EGF mRNA also declined in asso-
ciation with the development of renal 
microcysts in the HIV-Tg 26 mouse model 
of HIVAN, further linking diminished 
EGF levels to microcystic transformation 
of tubule epithelium. Urinary FGF-2 lev-
els were examined because systemic ele-
vation of FGF-2 had previously been 
associated with mesangial hyperplasia, 
focal segmental glomerulosclerosis, and /
 or microcystic transformation of renal 
tubules in rodents and monkeys. The 
investigators found that FGF-2 was 
increased in the urine of HIV-infected 
children who developed HIVAN ( Figure 
1 ), relative to levels detected in uninfected 
children or HIV-infected children who 
did not develop HIVAN. 2 Elevated FGF-
2 levels were corroborated in diseased 
HIV-Tg 26 mouse kidneys, in which both 
FGF-2 and FGF-binding protein-1 accu-
mulated as EGF production declined 
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 Soler-Garc í a and collaborators show that changing levels of urinary 
biomarkers associated with the pathology of HIV-associated 
nephropathy may identify HIV-infected children at greatest risk for this 
complication. These changes appear relatively early in disease 
progression and remain responsive to antiviral therapy. Will these trends 
be borne out in a multicenter study? 
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coincident with renal microcyst forma-
tion. Urinary MMP levels were investi-
gated because elevation of MMPs has 
long been associated with tubule-cell 
transformation and renal remodeling. 
MMP-2 was examined in particular 
because it is induced by FGF-2 in cells 
harvested from patients with AIDS –
 Kaposi ’ s sarcoma, and elevated levels of 
both MMP-2 and FGF-2 are detected in 
the urine of patients with AIDS – Kaposi ’ s 
sarcoma. - e investigators speculate that 
FGF-2 and MMP-2 may play similar roles 
in the pathogenesis of HIVAN because 
MMP-2 elevation is consistently detected 
in the urine of HIV-infected children 
with HIVAN and HIV-Tg 26 mice coinci-
dent with elevated FGF-2 and disease 
progression. All three urinary biomarkers 
are responsive to antiviral therapy and 
may serve as clinical correlates of thera-
peutic efficacy in  susceptible HIV-
infected children. 
 Although the three proposed biomark-
ers correlate well with clinical criteria for 
HIVAN (proteinuria, renomegaly, pro-
gressive decrease in glomerular ( ltration 
rate), there is a broad spectrum of renal 
disorders to be considered in HIV-
infected patients. 1,3 - ese include arterio-
nephrosclerosis, glomerulonephritis, 
chronic pyelonephritis, and interstitial 
nephritis. HIVAN a: ects both glomeruli 
and tubules, whereas other disorders pri-
marily involve one or the other. A panel of 
urine protein charge forms, such as   1 -
microglobulin and retinol-binding pro-
tein, may be useful in separating the 
causes of glomerular disease. 4 Because 
EGF is produced by the renal tubules, it is 
a potentially useful biomarker in a variety 
of tubulointerstitial disorders. Urinary 
excretion of EGF is reduced in children 
with congenital obstructive nephropathy, 
as well as in rodents with experimental 
ureteral obstruction. 5 Urinary excretion 
of matrix metalloproteinase-9 (MMP-9) 
is increased in children with acute 
pyelonephritis, and renal MMP-9 is 
increased in a mouse model of pyelo-
nephritis. 6 Although the use of a panel of 
biomarkers such as these may not distin-
guish the cause of renal disease in HIV-
infected children, this noninvasive 
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were observed for urinary FGF-2 and 
MMP-2, although the di: erences were less 
dramatic. In a study just published, Z ü rbig 
 et al. analyzed the low – molecular weight 
urinary proteomes of healthy individuals 
(2 – 73 years of age) to examine renal age-
related changes in the urinary proteome. 
- ey found temporal variation in the secre-
tion of 325 of over 5000 urinary peptides. 10 
- e majority of age-related di: erences were 
associated with renal development before 
or during puberty, whereas the remaining 
49 peptides were related to aging in adults. 
Of the 49 adult peptides, the majority are 
also markers of chronic kidney disease, 
suggesting a high correspondence between 
aging and chronic renal disease. 10 - us, the 
dynamic nature of the  ‘ normal ’ urinary 
proteome presents its own challenges as 
values change over a lifetime. Despite these 
complexities, the future of urinary biomar-
kers in clinical diagnostics remains bright 
and the need great where invasive strategies 
are the only current option. 
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approach could identify candidates for 
renal biopsy and would be useful in mon-
itoring the renal response to therapy. 
 Diagnostic urinary proteomics as a ( eld 
is still in its infancy. Biomarkers discov-
ered with one technology necessarily 
exclude entire classes of biologically rele-
vant proteins because of limits in detection 
sensitivity. Mass spectrometry can distin-
guish di: erences among moderately abun-
dant urinary proteins and has been used 
successfully to predict outcomes for infants 
born with ureteropelvic junction obstruc-
tion with respect to need for corrective 
surgery. 7 Di: erential pro( les of more than 
50 peptides were used to make predictions 
of high speci( city and sensitivity. 7 How-
ever, mass spectrometry cannot detect 
low-abundance biologically active pep-
tides such as growth factors and cytokines 
known to contribute to the pathology of 
this disease. Conversely, investigators who 
take a targeted approach to biomarker dis-
covery ignore larger proteome changes to 
focus on low-abundance molecules associ-
ated with a particular pathology, as in the 
case of the HIVAN biomarker profile 
reported by Soler-Garc í a  et al. 2 Additional 
biomarkers to the HIVAN profile may 
eventually include markers shared with 
other progressive renal diseases with com-
mon end points (for example, tubular 
injury, inF ammation, or glomerulosclero-
sis), whereas other markers may be limited 
to a subset of pathologies speci( cally asso-
ciated with HIVAN. Recently, three uri-
nary biomarkers were identi( ed for early 
detection of acute kidney injury (AKI) in 
children. - is panel includes neutrophil 
gelatinase – associated lipocalin (NGAL), 
interleukin-18 (IL-18), and kidney injury 
molecule 1 (KIM-1). 8 Urinary NGAL 
elevation was the earliest indication of AKI 
but not an AKI-specific response; this 
response also occurs in renal diseases that 
include inflammation or nephrotoxic 
components. Urinary KIM-1 and IL-18 
were intermediate biomarkers for AKI, 
with IL-18 appearing to be the most AKI-
speci( c marker of the three. 8 Pro( les con-
sisting of common and speci( c urinary 
biomarkers of renal disease may ultimately 
de( ne stages of disease progression that 
can aid in the selection of appropriate 
treatment and in subsequent assessment 
of therapeutic eK  cacy. 
 For biomarkers to move from research 
laboratory to clinic for diagnostics, inter-
pretation will depend on establishing the 
range of normal values over a lifespan so 
that patient values can be compared with 
an age-appropriate norm. Research indi-
cates that the normal urinary proteome is 
highly dynamic, changing with stage of 
renal development, functional maturation, 
and age. Lee  et al. have identi( ed temporal 
changes in the neonatal and young adult rat 
urinary proteomes that correlate with com-
pletion of nephrogenesis (postnatal in the 
rat), glomerular maturation, and sexual 
maturity. 9 Proteins associated with cell pro-
liferation and di: erentiation, cell adhesion, 
and tissue remodeling were prominent 
during periods of active nephron develop-
ment and functional maturation of the kid-
ney. 9 In the HIVAN biomarker study, 
urinary EGF levels were very high in 
healthy children under the age of 2 with 
functionally immature kidneys, and these 
levels steadily declined in prepubescent 
(2 – 12 years) and pubescent children 
( > 12 years). 2 Similar age-related declines 
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 Figure 1  |  Predictive trends in urinary biomarker concentrations. Green curve represents 
temporal loss of proteins that may be associated with renal-cell homeostasis (EGF), whereas 
orange and rose curves represent increasing levels of proteins associated with renal injury and / or 
fibrosis (FGF-2 and MMP-2) as renal pathology increases in HIVAN. 
